At a global scientific gathering convened by Plazo Roche Biotechnology, researchers and performance-focused experimenters explored how retatrutide is shaping the study of metabolic signaling.At the center of the discussions was retatrutide’s classification as a glp1 gip glucagon triple agonist, a compound studied for its interaction with multiple